Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EORTC CLTF 2021 | Integrating data to improve CBCL diagnosis

Jean-Philippe Merlio • 14 Oct 2021
EORTC CLTF 2021
B-Cell Lymphoma Cutaneous B-Cell Lymphoma Lymphoma Non-Hodgkin Lymphoma Rare Diseases

Jean-Philippe Merlio, MD, PhD, Tumor Biology and Tumor Bank, CHU Bordeaux, Pessac, France, comments on his work proposing new ways of integrating data on cutaneous B-cell lymphoma (CBCL), in contrast to standard classifications, to improve the diagnosis of patients with CBCL. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.

More from Jean-Philippe Merlio

1:05
Discrepancies in CBCL diagnosis
Jean-Philippe Merlio • 14 Oct 2021
1:19
Challenges in CBCL research
Jean-Philippe Merlio • 14 Oct 2021
2:25
The diagnostic work-up of CBCL
Jean-Philippe Merlio • 14 Oct 2021

Related Videos

3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
2:11
The role of CAR-T therapy for lymphoma in 2024: expert session highlights
Sridhar Chaganti • 16 Apr 2024
3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
1:32
Promising novel immunotherapeutic approaches in lymphoma
Gloria Iacoboni • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals